Wolverine Asset Management’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153 | Hold |
4,620
| – | – | ﹤0.01% | 1100 |
|
|
2025
Q1 | $161 | Sell |
4,620
-4,035
| -47% | -$141 | ﹤0.01% | 1100 |
|
|
2024
Q4 | $651 | Sell |
8,655
-6,864
| -44% | -$516 | ﹤0.01% | 1100 |
|
|
2024
Q3 | $558 | Buy |
15,519
+200
| +1% | +$7 | ﹤0.01% | 1108 |
|
|
2024
Q2 | $726 | Sell |
15,319
-7,464
| -33% | -$354 | ﹤0.01% | 1129 |
|
|
2024
Q1 | $888 | Sell |
22,783
-27
| -0.1% | -$1 | ﹤0.01% | 1120 |
|
|
2023
Q4 | $688 | Buy |
22,810
+10,045
| +79% | +$303 | ﹤0.01% | 1205 |
|
|
2023
Q3 | $893 | Buy |
12,765
+3,400
| +36% | +$238 | ﹤0.01% | 1300 |
|
|
2023
Q2 | $977 | Sell |
9,365
-3,425
| -27% | -$357 | ﹤0.01% | 1257 |
|
|
2023
Q1 | $460 | Hold |
12,790
| – | – | ﹤0.01% | 1402 |
|
|
2022
Q4 | $601 | Buy |
12,790
+11,169
| +689% | +$525 | ﹤0.01% | 1574 |
|
|
2022
Q3 | $0 | Buy |
+1,621
| New | – | ﹤0.01% | 2192 |
|
|
2021
Q3 | – | Sell |
-11,855
| Closed | -$10K | – | 2029 |
|
|
2021
Q2 | $10K | Sell |
11,855
-35,209
| -75% | -$29.7K | ﹤0.01% | 1732 |
|
|
2021
Q1 | $28K | Buy |
+47,064
| New | +$28K | ﹤0.01% | 1475 |
|